Gynaecological cancer articles within Scientific Reports

Featured

• Article
  29 April 2024 | Open Access

  Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer

  • Yifan Cheng
  • , Qing Li
  •  & Peng Wang

• Article
  16 April 2024 | Open Access

  Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia

  • Švitrigailė Grincevičienė
  • , Daiva Vaitkienė
  •  & Jurgita Matulienė

• Article
  13 April 2024 | Open Access

  Prediction of hematologic toxicity in luminal type breast cancer patients receiving neoadjuvant chemotherapy using CT L1 level skeletal muscle index

  • Min Chen
  • , Pinxiu Wang
  •  & Wenzhen Yuan

• Article
  05 April 2024 | Open Access

  Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer

  • Yoo-Na Kim
  • , Yun Soo Chung
  •  & Jung-Yun Lee

• Article
  30 March 2024 | Open Access

  Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma

  • Ngoc Le Tran
  • , Yao Wang
  •  & Guiying Nie

• Article
  18 March 2024 | Open Access

  The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of harmine and their crosstalk

  • Jun Zhu
  • , Hong Zhu
  •  & Jun Gao

• Article
  13 March 2024 | Open Access

  A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma

  • Yiqing Sun
  • , Kaiwen Zhang
  •  & Yingmei Wang

• Article
  28 February 2024 | Open Access

  Relationship among post-traumatic growth, spiritual well-being, and perceived social support in Chinese women with gynecological cancer

  • Yue Feng
  • , Xingcan Liu
  •  & Jing Chen

• Article
  27 February 2024 | Open Access

  Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and ¹⁸F-FDG PET/CT parameters

  • Junyu Zhang
  • , Siyu Niu
  •  & Haiyan Liu

• Article
  21 February 2024 | Open Access

  Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma

  • Qi Zhang
  • , Yongfu Luo
  •  & Gang Liu

• Article
  03 February 2024 | Open Access

  Mechanical activation and expression of HSP27 in epithelial ovarian cancer

  • Molly Buckley
  • , Maranda Kramer
  •  & Mary Kathryn Sewell-Loftin

• Article
  24 January 2024 | Open Access

  The prognostic value of radiological and pathological lymph node status in patients with cervical cancer who underwent neoadjuvant chemotherapy and followed hysterectomy

  • Jianghua Lou
  • , Xiaoxian Zhang
  •  & Meiyun Wang

• Article
  12 January 2024 | Open Access

  Comparing deep learning and handcrafted radiomics to predict chemoradiotherapy response for locally advanced cervical cancer using pretreatment MRI

  • Sungmoon Jeong
  • , Hosang Yu
  •  & Jae-Chul Kim

• Article
  02 January 2024 | Open Access

  MAD2L2, a key regulator in ovarian cancer and promoting tumor progression

  • Kejun Xu
  • , Xiaojiao Zheng
  •  & Huiqing Ding

• Article
  19 December 2023 | Open Access

  Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer

  • Patrícia Rocha Martins
  • , Kátia Luciano Pereira Morais
  •  & Kenneth J. Gollob

• Article
  19 December 2023 | Open Access

  Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2^MUT ovarian cancer cells

  • Łukasz Biegała
  • , Arkadiusz Gajek
  •  & Aneta Rogalska

• Article
  18 December 2023 | Open Access

  Characterization and prognostic impact of ACTBL2-positive tumor-infiltrating leukocytes in epithelial ovarian cancer

  • N. E. Topalov
  • , D. Mayr
  •  & B. Czogalla

• Article
  14 December 2023 | Open Access

  Analysis of long non-coding RNAs associated with disulfidptosis for prognostic signature and immunotherapy response in uterine corpus endometrial carcinoma

  • Bohan Li
  • , Xiaoling Li
  •  & Chao Wu

• Article
  11 December 2023 | Open Access

  Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer

  • Nikki L. Burdett
  • , Madelynne O. Willis
  •  & Elizabeth L. Christie

• Article
  08 December 2023 | Open Access

  Reproducible and clinically translatable deep neural networks for cervical screening

  • Syed Rakin Ahmed
  • , Brian Befano
  •  & Jayashree Kalpathy-Cramer

• Article
  27 November 2023 | Open Access

  Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer

  • David P. Mysona
  • , Sharad Purohit
  •  & Sharad Ghamande

• Article
  26 November 2023 | Open Access

  FT-Raman data analyzed by multivariate and machine learning as a new methods for detection spectroscopy marker of platinum-resistant women suffering from ovarian cancer

  • Marta Kluz-Barłowska
  • , Tomasz Kluz
  •  & Joanna Depciuch

• Article
  08 November 2023 | Open Access

  Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy

  • Rong-Rong Wu
  • , Yi-Min Zhou
  •  & Wen-Juan Chen

• Article
  07 November 2023 | Open Access

  Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer

  • Magdalena Niemira
  • , Anna Erol
  •  & Adam Kretowski

• Article
  06 November 2023 | Open Access

  9-oxo-ODAs suppresses the proliferation of human cervical cancer cells through the inhibition of CDKs and HPV oncoproteins

  • Kazumasa Mogi
  • , Yoshihiro Koya
  •  & Hiroaki Kajiyama

• Article
  06 November 2023 | Open Access

  Metronomic and single high-dose paclitaxel treatments produce distinct heterogenous chemoresistant cancer cell populations

  • Carolina Mejia Peña
  • , Thomas A. Skipper
  •  & Michelle R. Dawson

• Article
  02 November 2023 | Open Access

  Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

  • Benjamin Wolf
  • , Laura Weydandt
  •  & Bahriye Aktas

• Article
  14 October 2023 | Open Access

  The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer

  • Audrey Marjamaa
  • , Bettine Gibbs
  •  & Chioniso Patience Masamha

• Article
  10 October 2023 | Open Access

  Validation of an on-chip p16^ink4a/Ki-67 dual immunostaining cervical cytology system using microfluidic device technology

  • Kei Hashimoto
  • , Tomoo Kumagai
  •  & Kazunori Nagasaka

• Article
  02 October 2023 | Open Access

  High-fat diet promotes tumor growth in the patient-derived orthotopic xenograft (PDOX) mouse model of ER positive endometrial cancer

  • Ke Shen
  • , Dandan Shen
  •  & Li Yang

• Article
  29 September 2023 | Open Access

  A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer

  • Feng Zhan
  • , Lidan He
  •  & Lili Wang

• Article
  21 September 2023 | Open Access

  Validation of the diagnostic efficacy of O-RADS in adnexal masses

  • Na Su
  • , Ya Yang
  •  & Yuxin Jiang

• Article
  12 September 2023 | Open Access

  Increased expression of HPV-E7 oncoprotein correlates with a reduced level of pRb proteins via high viral load in cervical cancer

  • Bilal Ahmad Mir
  • , Arif Ahmad
  •  & P. F. Rahaman

• Article
  31 July 2023 | Open Access

  MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway

  • Shijie Wei
  • , Yubao Zhang
  •  & Jing Zhuang

• Article
  25 July 2023 | Open Access

  Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study

  • Shogo Shigeta
  • , Muneaki Shimada
  •  & Mikio Mikami

• Article
  24 July 2023 | Open Access

  Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study

  • Ryota Tashiro
  • , Hitoshi Kawazoe
  •  & Tomonori Nakamura

• Article
  20 July 2023 | Open Access

  Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study

  • Ki Eun Seon
  • , Yong Jae Lee
  •  & Sang Wun Kim

• Article
  03 July 2023 | Open Access

  Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer

  • Xiaoyu Kong
  • , Yuanpeng Xiong
  •  & Liping Li

• Article
  09 June 2023 | Open Access

  Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer

  • Bing Xue
  •  & Xihai Wang

• Article
  08 June 2023 | Open Access

  Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer

  • Yue Zhang
  • , Shasha Fan
  •  & Jingjing Wang

• Article
  07 June 2023 | Open Access

  A nomogram for predicting cancer-specific survival in patients with uterine clear cell carcinoma: a population-based study

  • Wen-li Cheng
  • , Rui-min Wang
  •  & Juan Chen

• Article
  07 June 2023 | Open Access

  Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma

  • Siyuan Song
  • , Haoqing Gu
  •  & Peng Shu

• Article
  05 June 2023 | Open Access

  Value of [¹⁸F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer

  • Ewa Burchardt
  • , Agnieszka Bos-Liedke
  •  & Julian Malicki

• Article
  26 May 2023 | Open Access

  Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes

  • Nanna Bæk Møller
  • , Desirée Sofie Boonen
  •  & Thorkild Terkelsen

• Article
  13 May 2023 | Open Access

  Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma

  • Jacopo Azzollini
  • , Luca Agnelli
  •  & Siranoush Manoukian

• Article
  11 May 2023 | Open Access

  Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

  • Robert L. Hollis
  • , John P. Thomson
  •  & C. Simon Herrington

• Article
  11 April 2023 | Open Access

  Conservative management of early-stage endometrial cancer for fertility preservation: a survey study among Swedish gynecologists and gynecological oncologists

  • Stavros I. Iliadis
  •  & Pietro Gambadauro

• Article
  04 April 2023 | Open Access

  Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer

  • Aoife Ward Gahlawat
  • , Tania Witte
  •  & Sarah Schott

• Article
  31 March 2023 | Open Access

  Assessment of pathogenic variation in gynecologic cancer genes in a national cohort

  • Urška Kotnik
  • , Aleš Maver
  •  & Luca Lovrecic

• Article
  24 March 2023 | Open Access

  Tracheoesophageal fistula treated with magnetic compression technique in canines

  • Yixing Li
  • , Miaomiao Zhang
  •  & Xiaopeng Yan